Antiphospholipid antibodies as potential predictors of disease severity and poor prognosis in systemic lupus erythematosus-associated thrombocytopenia: results from a real-world CSTAR cohort study

MLA

Jun Li, et al. “Antiphospholipid Antibodies as Potential Predictors of Disease Severity and Poor Prognosis in Systemic Lupus Erythematosus-Associated Thrombocytopenia: Results from a Real-World CSTAR Cohort Study.” Arthritis Research & Therapy, vol. 26, no. 1, Mar. 2024, pp. 1–7. EBSCOhost, https://doi.org/10.1186/s13075-024-03305-w.

APA

Jun Li, Liying Peng, Lijun Wu, Yufang Ding, Xinwang Duan, Jian Xu, Wei Wei, Zhen Chen, Cheng Zhao, Min Yang, Nan Jiang, Shangzhu Zhang, Qian Wang, Xinping Tian, Mengtao Li, Xiaofeng Zeng, Yan Zhao, & Jiuliang Zhao. (2024). Antiphospholipid antibodies as potential predictors of disease severity and poor prognosis in systemic lupus erythematosus-associated thrombocytopenia: results from a real-world CSTAR cohort study. Arthritis Research & Therapy, 26(1), 1–7. https://doi.org/10.1186/s13075-024-03305-w

Chicago

Jun Li, Liying Peng, Lijun Wu, Yufang Ding, Xinwang Duan, Jian Xu, Wei Wei, et al. 2024. “Antiphospholipid Antibodies as Potential Predictors of Disease Severity and Poor Prognosis in Systemic Lupus Erythematosus-Associated Thrombocytopenia: Results from a Real-World CSTAR Cohort Study.” Arthritis Research & Therapy 26 (1): 1–7. doi:10.1186/s13075-024-03305-w.